YIH
Y-Intercept (HK) Portfolio holdings
AUM
$4.09B
1-Year Return
5.6%
This Quarter Return
+8.15%
1 Year Return
+5.6%
3 Year Return
+25.71%
5 Year Return
–
10 Year Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.58B
Cap. Flow
% of AUM
63.04%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| 1 |
Nu Holdings
NU
|
+$31.8M |
| 2 |
UnitedHealth
UNH
|
+$30.9M |
| 3 |
T-Mobile US
TMUS
|
+$29.7M |
| 4 |
Rocket Lab Corporation Common Stock
RKLB
|
+$27.8M |
| 5 |
Intel
INTC
|
+$25.4M |
Top Sells
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Novo Nordisk
NVO
|
+$16.4M |
| 3 |
Marvell Technology
MRVL
|
+$16.2M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart
WMT
|
+$11.1M |
Sector Composition
| 1 | Technology | 15.92% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.31% |
| 4 | Healthcare | 12.55% |
| 5 | Consumer Discretionary | 12.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
C4 Therapeutics
CCCC
$188M
| $75.1K | ﹤0.01% |
+52,521
| New | +$75.1K |
|
1552
Blink Charging
BLNK
$129M
| $64K | ﹤0.01% |
+68,042
| New | +$64K |
|
1553
JetBlue
JBLU
$1.85B
| $62.5K | ﹤0.01% |
+14,774
| New | +$62.5K |
|
|
BOLD
1554
Boundless Bio
BOLD
$26M
| $55.8K | ﹤0.01% |
+55,242
| New | +$55.8K |
|
|
DDL
1555
Dingdong
DDL
$462M
| $54.2K | ﹤0.01% |
+26,818
| New | +$54.2K |
|
1556
Ovid Therapeutics
OVID
$88.9M
| $52.9K | ﹤0.01% |
+160,306
| New | +$52.9K |
|
1557
Aemetis
AMTX
$136M
| $51K | ﹤0.01% |
+20,556
| New | +$51K |
|
1558
Century Therapeutics
IPSC
$43.9M
| $50.3K | ﹤0.01% |
+89,975
| New | +$50.3K |
|
1559
JELD-WEN Holding
JELD
$537M
| $49K | ﹤0.01% |
+12,497
| New | +$49K |
|
|
ARTV
1560
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$65.9M
| $47.7K | ﹤0.01% |
+31,567
| New | +$47.7K |
|
1561
Sutro Biopharma
STRO
$77.2M
| $47.5K | ﹤0.01% |
+66,591
| New | +$47.5K |
|
1562
Generation Bio
GBIO
$40.3M
| $47.4K | ﹤0.01% |
+14,819
| New | +$47.4K |
|
1563
Adverum Biotechnologies
ADVM
$69.5M
| $45.4K | ﹤0.01% |
+21,122
| New | +$45.4K |
|
|
FSP
1564
Franklin Street Properties
FSP
$172M
| $43.2K | ﹤0.01% |
+26,332
| New | +$43.2K |
|
1565
Cardlytics
CDLX
$49.8M
| $42.4K | ﹤0.01% |
+25,789
| New | +$42.4K |
|
1566
Skye Bioscience
SKYE
$128M
| $42K | ﹤0.01% |
+10,046
| New | +$42K |
|
1567
Neumora Therapeutics
NMRA
$264M
| $41.9K | ﹤0.01% |
+57,072
| New | +$41.9K |
|
1568
SES AI
SES
$410M
| $41.3K | ﹤0.01% |
+46,493
| New | +$41.3K |
|
1569
Prelude Therapeutics
PRLD
$67.4M
| $38.7K | ﹤0.01% |
+47,788
| New | +$38.7K |
|
1570
Zentalis Pharmaceuticals
ZNTL
$105M
| $38K | ﹤0.01% |
+32,740
| New | +$38K |
|
1571
Kaltura
KLTR
$255M
| $37.9K | ﹤0.01% |
+18,873
| New | +$37.9K |
|
1572
FibroBiologics
FBLG
$22.8M
| $37K | ﹤0.01% |
+59,539
| New | +$37K |
|
1573
MacroGenics
MGNX
$109M
| $36.2K | ﹤0.01% |
+29,945
| New | +$36.2K |
|
1574
Black Diamond Therapeutics
BDTX
$183M
| $36K | ﹤0.01% |
+14,521
| New | +$36K |
|
1575
Zynex
ZYXI
$44.2M
| $35.8K | ﹤0.01% |
+13,873
| New | +$35.8K |
|